ALAS1 and autoimmune pancreatitis: It is important to recall that the mechanism of haem therapy is to reduce the transcription of ALAS1 [16], which is not increased in the mouse model of this condition and may not be significantly upregulated to the degree previously observed in acute attacks of AIP if this condition is a fixed bottleneck rather than an inducible condition.